Initial Clinical Experience with [177Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry.

已取消 20 由 Luke 发布于 2026/3/9 16:13:21

DOI:10.2967/jnumed.125.271031
作者：Lisa Glantschnig,Johanna S Enke,Bradley W Schuller,Eric J Fenn,Alexander Dierks,Marianne Patt,Andreas Rinscheid,Robert Seifert,Lena M Unterrainer,Lars H Lindner,Dorit Di Gioia,John W Babich,Alejandro
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

其它数据库

Abstract：This series of case studies provides the first clinical experience with the fibroblast activation protein-α (FAP)-targeting radiopharmaceutical [177Lu]Lu-RTX-2358 in patients with advanced s

应助信息

2026-03-09

Book学术机器人

2026/3/9 16:13:21 未找到该文献，机器人已退出，请等待人工下载

2026/3/9 16:13:21 Book学术AI机器人收到请求，开始寻找文献

2026/3/9 16:13:21 已向机器人发送请求

2026-03-09

Luke 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierSynergetic effects of nanohybrids in cement-based materials